Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Naloxone Project is a healthcare-focused non-profit organization dedicated to reducing opioid overdose deaths by increasing the availability and distribution of naloxone. Founded by emergency physicians, the organization partners with hospitals and health systems to implement Naloxone Champion programs, ensuring that patients at risk of overdose receive the life-saving medication upon discharge. Their work focuses on clinical education, policy advocacy, and streamlining the supply chain for harm reduction tools. By bridging the gap between clinical care and community health, they aim to make naloxone a standard part of medical practice for at-risk populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Naloxone Project.